• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. FINESSE ULTRA 14G PROBE; BIOPSY INSTURMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. FINESSE ULTRA 14G PROBE; BIOPSY INSTURMENT Back to Search Results
Catalog Number F14105US
Device Problems Difficult to Remove (1528); Failure to Disconnect (2541); Device Displays Incorrect Message (2591)
Patient Problems No Consequences Or Impact To Patient (2199); No Known Impact Or Consequence To Patient (2692)
Event Date 12/19/2013
Event Type  malfunction  
Manufacturer Narrative
A further clinical review of the event details was completed and a change in the mdr reportability was identified.No medical records or no medical images have been made available to the manufacturer.As the lot number for the device was provided, a review of the device history records is currently being performed.The device has not been returned to the manufacturer for evaluation.The investigation of the reported event is currently underway.The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Event Description
It was reported that the physician fired into the lesion (fatty breast), pressed the sample button and after sampling the device went into orange lights mode/orange lights flashing simultaneously.The physician tried to disconnect the probe from the coaxial but was unsuccessful.Physician had to forcefully pull the probe out of the breast and was able to retrieve the specimen from the probe.Completed the procedure with a another probe.There was no reported patient injury.
 
Manufacturer Narrative
Manufacturing review: a manufacturing review was conducted.The lot met all release criteria.Visual/microscopic inspection: as the device was not returned, an inspection could not be performed.Functional/performance evaluation: as the device was not returned, an evaluation could not be performed.Medical records review: as medical records were not provided, a review could not be performed.Image/photo review: no medical images have been made available to the manufacturer.Conclusion: the investigation is inconclusive, as the probe was not returned for evaluation.Per the event description, it was noted that the breast tissue was fatty; therefore it is possible that patient factors contributed to the event.However, the definitive root cause could not be determined based upon available information.Labeling review: the current instructions for use (ifu) states: precautions 1.Do not use the finesse® ultra biopsy probe without the integrated coaxial cannula.The integrated coaxial cannula may be removed after the biopsy to retain a track to the biopsy site when placing a tissue marker.2.The finesse® ultra breast biopsy system should only be used by a physician trained in its indicated use, limitations, and possible complications of percutaneous needle techniques.Potential complications 1.Potential complications are those associated with any percutaneous removal/ biopsy technique for tissue collection.Potential complications are limited to the region surrounding the biopsy site and include hematoma, hemorrhage, infection, a non-healing wound, pain and tissue adherence to the biopsy probe while removing it from the breast.2.As per routine biopsy procedures, it may be necessary to cut tissue adhering to the biopsy probe while removing it from the breast.The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FINESSE ULTRA 14G PROBE
Type of Device
BIOPSY INSTURMENT
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 west 3rd st.
tempe AZ 85281
Manufacturer (Section G)
FERROSAN MEDICAL DEVICES SP. Z O.O
ul. koksowa 3
70-031 szczecin
PL  
Manufacturer Contact
judith ludwig
1625 west 3rd st.
tempe, AZ 85281
4803032689
MDR Report Key5352483
MDR Text Key35676557
Report Number2020394-2016-00009
Device Sequence Number1
Product Code KNW
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K093068
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Medical Technologist
Type of Report Initial,Followup
Report Date 12/19/2013
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/07/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/30/2016
Device Catalogue NumberF14105US
Device Lot Number91003575
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/17/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/25/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-